Dermatological presentation of disease associated with antineutrophil cytoplasmic antibodies: A report of two contrasting cases and a review of the literature

British Journal of Dermatology

Volumn 134, Issue 5, 1996, Pages 924-928

  Irvine, A D ^a   Bruce, I N ^a   Walsh, M ^a   Burrows, D ^a   Handley, J ^a  

^a ROYAL VICTORIA HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CASE REPORT; GENITAL ULCER; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PYODERMA GANGRENOSUM; VASCULITIS;

EID: 0029920548     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.1996.tb06327.x     Document Type: Article

References (30)

1. Jennette JC, Falk FJ. Antineutrophil cytoplasmic antibodies and associated diseases: a review. Am J Kidney Dis 1990; 15: 517-29.
2. Wiik A. Delineation of a standard procedure for indirect immunofluorescent detection of ANCA. Acta Pathol Microbiol Immunol Scand 1989; 97 (Suppl.): 12-13.
3. Gross WL, Mauschild S, Mistraz N. The clinical relevance of ANCA in vasculitis. Clin Exp Immunol 1993; 93 (Suppl. 1): 7-11.
4. Reed WB, Jensen AK, Konwaler BE et al. The cutaneous manifestations in Wegener's granulomatosis. Acta Derm Venereol (Stockh) 1963; 43: 250-64.
5. Falk RJ, Terrell RG, Charles LA et al. Anti-neutrophil cytoplasmic antibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. Proc Natl Acad Sci USA 1990; 87: 4115-19.
6. Jennette JC, Ewert BM, Falk RJ. Do antineutrophil cytoplasmic autoantibodies cause Wegener's granulomatosis and other forms of necrotizing vasculitis. Rheum Dis Clin North Am 1993; 19: 1-4.
7. Deremee RA, McDonald TJ, Weiland LM. Wegener's granulomatosis: observations on treatment with antimicrobial agents. Mayo Clin Proc 1985; 60: 27-32.
8. Peter HH, Metzger D, Rump A et al. ANCA in diseases other than systemic vasculitis. Clin Exp Immunol 1993; 93 (Suppl. 1): 12-13.
9. Jennette JC, Falk RJ, Andrassy K et al. Nomenclature of systemic vasculidites. Proposal of an International Consensus Conference. Arthritis Rheum 1994; 37: 187-92.
10. Savage COS, Winearls CG, Evans DJ et al. Microscopic polyarteritis: presentation, pathology and prognosis. Q J Med 1985; 56: 467-83.
11. Fauci AS, Maynes BF, Katz P et al. Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med 1983; 98: 76-85.
12. Hu CH, O'Loughlin S, Winkelmann RK. Cutaneous manifestations of Wegener's granulomatosis. Arch Dermatol 1977; 113: 175-82.
13. Chyu JYM, Magstrom WJ, Soltani K et al. Wegener's granulomatosis in childhood: cutaneous manifestations as the presenting signs. J Am Acad Dermatol 1984; 10: 341-6.
14. Mangold MC, Callen JP. Cutaneous leucocytoclastic vasculitis associated with active Wegener's granulomatosis. J Am Acad Dermatol 1992; 26: 579-84.
15. Halstead LA, Kennedy CS, Wolff SM. Presentation of Wegener's granulomatosis in young patients. Otolaryngol Head Neck Surg 1986; 94: 368-71.
16. Thomas RHM, Payne CMER, Black MM. Wegener's granulomatosis presenting as pyoderma gangrenosum. Clin Exp Dermatol 1982; 7: 523-7.
17. Daoud S, Gibson LE, De Remee RA et al. Cutaneous Wegener's granulomatosis: Clinical, histopathological and immunopathological features of thirty patients. J Am Acad Dermatol 1994; 31: 605-12.
18. Hoffman GS, Kerr GS, Leavitt RY et al. Wegener's granulomatosis: an analysis of 158 patients. Ann Intern Med 1992; 116: 488-98.
19. Lerner EA, Dover JS. Malignant pyoderma: a manifestation of Wegener's granulomatosis? (letter). J Am Acad Dermatol 1986; 15: 1051-2.
20. Aymard B, Bigard MA, Thompson M et al. Perianal ulcer: an unusual presentation of Wegener's granulomatosis: report of a case. Dis Colon Rectum 1990; 33: 427-30.
21. Cupps TR, Fauci AS. Wegener's granulomatosis. Int J Dermatol 1980; 19: 76-80.
22. Kavanagh GM, Colaco CB, Bradfield JW, et al. Erythema elevatinum dilutinum associated with Wegener's granulomatosis and IgA paraproteinemia. J Am Acad Dermatol 1993; 28: 846-9.
23. Burrows NP, Lockwood CM. Antineutrophil tytoplasmic antibodies and their relevance to the dermatologist. Br J Dermatol 1995; 32: 173-81.
24. Cohen Tervaert JW, Woude FJ van der, Fauci AS et al. Association between active Wegener's granulomatosis and anticytoplasmic antibodies. Arch Intern Med 1989; 149: 2461-5.
25. Hind CRH, Winearls CG, Lockwood CM et al. Objective monitoring of activity in Wegener's granulomatosis by measurement of serum C-reactive protein concentration. Clin Nephrol 1984; 21: 341-5.
26. Luqmani RA, Bacon PA, Janssen BA et al. Birmingham vasculitis activity score (BVAS) (Abstr.). Clin Exp Immunol 1993; 93 (Suppl. 1): 35.
27. Venning MC, Quinn A, Broomhead V et al. Antibodies directed against neutrophils (cANCA and pANCA) are of distinct diagnostic value in systemic vasculitis. Q J Med 1990; 77: 1287-96.
28. Ramirez G, Khamashta MA, Hughes GRV. The ANCA test: its clinical relevance. Ann Rheum Dis 1990; 49: 741-2.
29. Gross WL, Schmilt WH, Csernok E. ANCA-associated diseases: immunodiagnostic and pathogenetic aspects. Clin Exp Immunol 1993; 91: 1-12.
30. Gordon M, Luqmani RA, Adu D et al. Necrotising vasculitis - relapse despite cytotoxic therapy. In: ANCA-associated Vasculidites: Immunological and Clinical Aspects (Gross WL, ed.). New York: Plenum Press, 1993; 477-81.